Center for Clinical Trial studies Our Centers for Clinical Trial Studies: A Phase III, Placebo-controlled, Randomized, Observer-blinded, Multi-national, Multi-center Study to Assess the Safety, Reactogenicity, and Immunogenicity of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) adjuvanted with AS03 in Adults Aged 18 Years and Older A Phase III, Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Evaluate Immune Non-Inferiority, Safety and Lot-To-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shancholâ„¢ in 1 to 40 years old Healthy Nepalese Participants A Parallel group phase III multi-stage modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS Cov-2 adjuvanted recombinant protein vaccines (Monovalent and Bivalent) for prevention against COVID-19 in adults 18 years of age and older (VAT00008) Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19 (KICC COVID-19)